ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Development of a Rat Model of Antibody-Mediated Rejection After Liver Transplantation

T. Tajima, K. Hata, J. Kusakabe, H. Miyauchi, S. Uemoto

Dept. of Surgery, Div. of HBP Surgery & Transplantation, Kyoto University Graduate School of Medicine, Kyoto, Japan

Meeting: 2021 American Transplant Congress

Abstract number: 524

Keywords: B cells, Liver transplantation, Rat, Rejection

Topic: Basic Science » B-cell / Antibody /Autoimmunity

Session Information

Session Name: B-cell / Antibody /Autoimmunity

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Antibody-mediated rejection (AMR) is a refractory rejection after donor-specific antibody (DSA)-positive or ABO blood-type incompatible liver transplantation (LT), due at least in part to lacking a standardized rodent model of AMR.

*Methods: Orthotopic LT was performed from male Dark Agouti rats (DA, 240-260g, donors) to male Lewis rats (LEW, 280-300g, recipients), served as non-sensitized controls (Group-NS). In pre-sensitized group (Group-PS), LEW were pre-sensitized by a preceding skin transplantat (2 x 2 cm2) from DA with subcutaneous aluminum adjuvant 4-6 weeks prior to LT.Tacrolimus was daily administered (0.1 mg/kg/day) after LT until sacrifice to suppress cellular rejections. Blood and liver tissues were sampled on post-transplant day (PTD)-1, -3, and -7 (n =5 each). Both IgG- and IgM-DSA titers in recipient sera were determined by flow cytometry.

*Results: AST, ALT, ALP, total bile-acid (TBA), and bilirubin were all significantly higher in Group-PS than in Group-NS (P<0.01). In particular, biliary damage markers, i.e. ALP, TBA, and bilirubin, were significantly deteriorated in Group-PS than in -NS on PTD-7 (P <0.001), followed by thrombocytopenia (P <0.05) and aggravated PT-INR (P <0.05). Histopathological grading (P <0.001) and C4d scores (P <0.001) were also significantly deteriorated in Group-PS than in -NS on PTD-7. As underlying mechanisms, we demonstrated significantly upregulated IgG- and IgM-DSA titers (P<0.001 and <0.05, respectively), accompanied with significantly-more infiltrated plasma cells to transplanted liver tissues (P <0.001) in Group-PS than in -NS on PTD-7.

*Conclusions: By a preceding skin sensitization with post-transplant tacrolimus, we developed a rat AMR model after LT that satisfies the Banff criteria for AMR diagnosis.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Tajima T, Hata K, Kusakabe J, Miyauchi H, Uemoto S. Development of a Rat Model of Antibody-Mediated Rejection After Liver Transplantation [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/development-of-a-rat-model-of-antibody-mediated-rejection-after-liver-transplantation/. Accessed May 30, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences